Sean Saint

That stands for Alternate Controller Enabled Insulin Pump.

And what it means is that you're right, there is no trial on the pump itself.

The trial is on the algorithm and, of course, there's a trial on the CGM side as well.

But we can do benchtop testing on the physical pump, get it approved as an ACE, and then pair it with our IAGC algorithm and our ICGM partners.

And then you have all three of those together, an AID system.

And sorry for the TLAs, which of course is three-letter acronym.

Yeah, we sure do.

Sorry about that.

Yeah, our public statement said that we intend to have an unconstrained launch by the end of 2027.

Meaning if you want one, you can get it by that time.

I look forward to that.

Yeah, you're absolutely right.

Biohormonal was the original founding concept of beta bionics.

And it's the concept of using insulin to bring your blood sugar down and glucagon to bring it back up again.

So that's the gas and the brakes of driving your car.

You know, you can drive a car without brakes, but it's a heck of a lot easier with them.

So glucagon is the brakes.

And it eliminates the need for people to really manage lows, which is something that everybody with diabetes deals with every single day.

And that is an important distinction.

There's been some lack of clarity on this in the past.